Publications & Multimedia

Cochrane reviews

Cochrane Reviews from READ-It Partners in the Cochrane Database of Systematic Reviews.

Supporting materials

Guidelines

Multimedia resources

READ-It annual reports

Other publications and stories

View all resources

1

Latest resources

Podcast: How accurate are rapid tests for diagnosing COVID-19?

Several COVID-19 reviews relate to diagnosis. One of these, on the use of rapid point-of-care tests was updated in March 2021. Lead author Jacqueline Dinnes from the University of Birmingham in the UK tells us what they found for antigen tests.

Update (24 Mar 2021): Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection

This is a review update of the original version (published 26 August 2020). The authors now include 64 study reports in 78 study cohorts, evaluating 16 antigen and 5 molecular assays.

Cochrane Systematic Review: UPDATE

1

Podcast: How accurate are rapid tests for diagnosing COVID-19?

Several COVID-19 reviews relate to diagnosis. One of these, on the use of rapid point-of-care tests was updated in March 2021. Lead author Jacqueline Dinnes from the University of Birmingham in the UK tells us what they found for antigen tests.

Update (24 Mar 2021): Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection

This is a review update of the original version (published 26 August 2020). The authors now include 64 study reports in 78 study cohorts, evaluating 16 antigen and 5 molecular assays.

Cochrane Systematic Review: UPDATE

Xpert MTB/RIF and Xpert Ultra assays for screening for pulmonary tuberculosis and rifampicin resistance in adults, irrespective of signs or symptoms.

How accurate are sputum Xpert tests for screening for active pulmonary tuberculosis and rifampicin resistance in adults whether or not they have tuberculosis symptoms?

Cochrane Systematic Review: NEW

Update (16 Mar 2021) Thoracic imaging tests for the diagnosis of COVID‐19

Original version published on 30 September 2020. This is the second update of this review. The review authors included studies in people with suspected COVID‐19 only, and excluded studies in people with confirmed COVID‐19. The evidence is up to date to 30 September 2020.

Cochrane Systematic Review: UPDATE

Podcast: How accurate are tests (Xpert Ultra and Xpert MTB/RIF) for diagnosing tuberculosis outside the lungs (extrapulmonary tuberculosis) and rifampicin resistance?

First author, Mikashmi Kohli from McGill University in Montreal Canada, tells us about the updating of the review and what they found.

Updated Podcast: Can symptoms and medical examination accurately diagnose COVID-19?

This review, first published in June 2020 has been updated in February 2021. Here the lead author, Thomas Struyf from the Katholieke Universiteit Leuven in Belgium, tells us about the latest findings.

Update (23 Feb 2021) Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19

This review update will assess the diagnostic accuracy of signs and symptoms to determine if a person presenting in primary care or to hospital outpatient settings, such as the emergency department or dedicated COVID‐19 clinics, has COVID‐19.

Cochrane Systematic Review: UPDATE

Update: Xpert Ultra versus Xpert MTB/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis

Why is improving the diagnosis of pulmonary tuberculosis important?

Cochrane Systematic Review: UPDATE

Chloroquine or hydroxychloroquine for prevention and treatment of COVID‐19

Hydroxychloroquine does not reduce deaths from COVID-19, and probably does not reduce the number of people needing mechanical ventilation, state the authors of a new Cochrane Review.

Cochrane Systematic Review: NEW

Integrated community case management of childhood illness in low‐ and middle‐income countries

This Cochrane Review aimed to assess the effects of integrated community case management (iCCM) for children under‐five in low‐ and middle‐income countries

Cochrane Systematic Review: NEW

Update:Atovaquone‐proguanil for treating uncomplicated Plasmodium falciparum malaria

What are the benefits and risks of atovaquone‐proguanil for treating uncomplicated malaria caused by the Plasmodium falciparum parasite?

Cochrane Systematic Review: UPDATE

Update: Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults

How accurate are tests (Xpert Ultra and Xpert MTB/RIF) for diagnosing tuberculosis outside the lungs (extrapulmonary tuberculosis) and rifampicin resistance?

Cochrane Systematic Review: UPDATE

Pages